Gallium-68 NOTA hGZP

N/A

Report date: 2025/11/20 16:00:57

NME

Base Information

Drug NameGallium-68 NOTA hGZP

Drug Alias Name[68Ga]-NOTA-hGZPCSB-111

ClassificationDiagnostic agent (In vivo) > Radionuclide Imaging agentRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Nuclides > Gallium > 68Ga +[5]

Mechanisms of ActionPositron-emission tomography enhancersIonising radiation emittersRadionuclide imaging enhancers

TargetsNot applicable

Therapy Area/IndicationsN/A

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesCytosite Biopharma Inc

China Registration ClassN/A

Develop Information

Active CompaniesCytosite Biopharma Inc

Inactive CompaniesN/A

Active IndicationsN/A

Inactive IndicationsN/A

Other Information

ATC CodeN/A